CD44 and head and neck squamous cell carcinoma: Having established that CD24 specifically affects cisplatin sensitivity of these HNSCC lines and arguably has no bearing on their early radiation sensitivity profile, we intended to study the expression pattern of CD24 and compare it with the prominent CSC marker CD44 in HNSCC tumor sections.